Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

<h4>Introduction</h4>Coronavirus disease 2019 (COVID-19) can lead to respiratory failure due to severe immune response. Treatment targeting this immune response might be beneficial but there is limited evidence on its efficacy. The aim of this study was to determine if early treatment of...

Full description

Bibliographic Details
Main Authors: Malgorzata Mikulska, Laura Ambra Nicolini, Alessio Signori, Antonio Di Biagio, Chiara Sepulcri, Chiara Russo, Silvia Dettori, Marco Berruti, Maria Pia Sormani, Daniele Roberto Giacobbe, Antonio Vena, Andrea De Maria, Chiara Dentone, Lucia Taramasso, Michele Mirabella, Laura Magnasco, Sara Mora, Emanuele Delfino, Federica Toscanini, Elisa Balletto, Anna Ida Alessandrini, Federico Baldi, Federica Briano, Marco Camera, Ferdinando Dodi, Antonio Ferrazin, Laura Labate, Giovanni Mazzarello, Rachele Pincino, Federica Portunato, Stefania Tutino, Emanuela Barisione, Bianca Bruzzone, Andrea Orsi, Eva Schenone, Nirmala Rosseti, Elisabetta Sasso, Giorgio Da Rin, Paolo Pelosi, Sabrina Beltramini, Mauro Giacomini, Giancarlo Icardi, Angelo Gratarola, Matteo Bassetti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237831

Internet

https://doi.org/10.1371/journal.pone.0237831

Similar Items